Life Sciences Venture Capital Firm Burrill To Set Up An India-focused Fund
Wed, 04/11/2007 - 02:42 — Sahad P VBurrill & Co., a leading US-based life sciences merchant bank-cum-venture capital fund, is raising two funds - one focused on India and the other on China, according to VentureWire.
Each fund is expected to raise between $100 million and $200 million.
The San Francisco-based firm is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $500 million under management.
Burrill's technical and venture investing capability spans the entire spectrum of life sciences.
